| Antidiabetic effect of brain-derived neurotrophic factor and its association with inflammation in type 2 diabetes mellitus C Eyileten, A Kaplon-Cieslicka, D Mirowska-Guzel, L Malek, M Postula Journal of diabetes research 2017, 2017 | 186 | 2017 |
| MicroRNAs as diagnostic and prognostic biomarkers in ischemic stroke—a comprehensive review and bioinformatic analysis C Eyileten, Z Wicik, S De Rosa, D Mirowska-Guzel, A Soplinska, C Indolfi, ... Cells 7 (12), 249, 2018 | 145 | 2018 |
| Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review J Pordzik, D Jakubik, J Jarosz-Popek, Z Wicik, C Eyileten, S De Rosa, ... Cardiovascular diabetology 18, 1-19, 2019 | 121 | 2019 |
| Genome-wide association study using pooled DNA to identify candidate markers mediating susceptibility to postoperative nausea and vomiting PK Janicki, R Vealey, J Liu, J Escajeda, M Postula, K Welker The Journal of the American Society of Anesthesiologists 115 (1), 54-64, 2011 | 103 | 2011 |
| The potential role of platelet-related microRNAs in the development of cardiovascular events in high-risk populations, including diabetic patients: a review J Pordzik, K Pisarz, S De Rosa, AD Jones, C Eyileten, C Indolfi, L Malek, ... Frontiers in endocrinology 9, 74, 2018 | 100 | 2018 |
| The relation of the brain-derived neurotrophic factor with microRNAs in neurodegenerative diseases and ischemic stroke C Eyileten, L Sharif, Z Wicik, D Jakubik, J Jarosz-Popek, A Soplinska, ... Molecular neurobiology 58 (1), 329-347, 2021 | 98 | 2021 |
| Baseline platelet size is increased in patients with acute coronary syndromes developing early stent thrombosis and predicts future residual platelet reactivity. A case-control … Z Huczek, KJ Filipiak, J Kochman, M Michalak, M Roik, R Piatkowski, ... Thrombosis Research 125 (5), 406-412, 2010 | 92 | 2010 |
| Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups G Gelbenegger, M Postula, L Pecen, S Halvorsen, M Lesiak, ... BMC medicine 17 (1), 1-16, 2019 | 89 | 2019 |
| ACE2 interaction networks in COVID-19: a physiological framework for prediction of outcome in patients with cardiovascular risk factors Z Wicik, C Eyileten, D Jakubik, SN Simões, DC Martins Jr, R Pavão, ... Journal of clinical medicine 9 (11), 3743, 2020 | 79 | 2020 |
| Ticagrelor–toward more efficient platelet inhibition and beyond MJ Kubisa, MP Jezewski, A Gasecka, JM Siller-Matula, M Postuła Therapeutics and clinical risk management, 129-140, 2018 | 62 | 2018 |
| Subclinical leaflet thrombosis after transcatheter aortic valve replacement: a meta-analysis M Bogyi, RE Schernthaner, C Loewe, GM Gager, AM Dizdarevic, ... Cardiovascular Interventions 14 (24), 2643-2656, 2021 | 61 | 2021 |
| Effects of environmental factors on severity and mortality of COVID-19 D Kifer, D Bugada, J Villar-Garcia, I Gudelj, C Menni, C Sudre, F Vučković, ... Frontiers in medicine 7, 607786, 2021 | 60 | 2021 |
| MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics D Jakubik, A Fitas, C Eyileten, J Jarosz-Popek, A Nowak, P Czajka, ... Cardiovascular diabetology 20, 1-29, 2021 | 57 | 2021 |
| Genetic determinants of platelet reactivity during acetylsalicylic acid therapy in diabetic patients: evaluation of 27 polymorphisms within candidate genes M Postula, A Kaplon‐Cieslicka, M Rosiak, A Kondracka, A Serafin, ... Journal of Thrombosis and Haemostasis 9 (11), 2291-2301, 2011 | 57 | 2011 |
| Early biomarkers of neurodegenerative and neurovascular disorders in diabetes A Gasecka, D Siwik, M Gajewska, MJ Jaguszewski, T Mazurek, KJ Filipiak, ... Journal of Clinical Medicine 9 (9), 2807, 2020 | 52 | 2020 |
| Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel A Gasecka, R Nieuwland, M Budnik, F Dignat‐George, C Eyileten, ... Journal of thrombosis and haemostasis 18 (3), 609-623, 2020 | 49 | 2020 |
| Novel antiplatelet agents in the prevention of cardiovascular complications–focus on ticagrelor MM Marczewski, M Postula, D Kosior Vascular health and risk management, 419-429, 2010 | 49 | 2010 |
| Long non-coding RNAs as promising therapeutic approach in ischemic stroke: a comprehensive review M Wolska, J Jarosz-Popek, E Junger, Z Wicik, T Porshoor, L Sharif, ... Molecular Neurobiology 58, 1664-1682, 2021 | 37 | 2021 |
| Association of adipokines and inflammatory markers with lipid control in type 2 diabetes A Kapłon-Cieślicka, M Postuła, M Rosiak, M Peller, A Kondracka, ... Pol Arch Med Wewn 125 (6), 414-423, 2015 | 36 | 2015 |
| Factors responsible for “aspirin resistance”-can we identify them? M Postuła, B Tarchalska-Kryńska, KJ Filipiak, D Kosior, A Serafin, ... Kardiologia Polska (Polish Heart Journal) 68 (4), 410-418, 2010 | 35 | 2010 |
